Insights

Expansion into International Markets Vericel's strategic plan to enter international markets between 2027 and 2028 presents an opportunity to offer geographic-specific solutions, including supply chain support, local partnerships, and regulatory consulting services aimed at accelerating their global footprint.

Product Launch Opportunities The recent launch of MACI Arthro and NexoBrid indicates ongoing product development and expansion into diverse therapeutic areas within the regenerative medicine space, suggesting opportunities for sales of complementary medical devices, biologics, and marketing collaborations.

Market Penetration in Sports Medicine and Burn Care Vericel’s focus on advanced therapies for sports medicine and severe burn care highlights a target demographic of hospitals, clinics, and specialists seeking innovative biologics, providing multiple avenues for key account sales and specialty distribution partnerships.

Participation in Major Conferences Active engagement in high-profile healthcare conferences like J.P. Morgan and Truist Securities indicates openness to strategic partnerships, licensing deals, and collaborations, making these events ideal for outreach and relationship-building with key decision-makers.

Financial Growth and Funding With revenues between 100 and 250 million dollars and ongoing funding efforts, Vericel displays strong market confidence, creating prospects for premium service offerings, joint ventures, and investment opportunities aligned with their growth ambitions.

Vericel® Corporation Tech Stack

Vericel® Corporation uses 8 technology products and services including SAS, Drupal, SQL, and more. Explore Vericel® Corporation's tech stack below.

  • SAS
    Business Intelligence
  • Drupal
    Content Management System
  • SQL
    Database
  • Adobe Acrobat Pro
    Editors
  • Microsoft Dynamics
    Enterprise Resource Planning
  • Google Fonts API
    Font Scripts
  • jQuery Mobile
    Mobile Frameworks
  • Office 365
    Office Suites

Media & News

Vericel® Corporation's Email Address Formats

Vericel® Corporation uses at least 1 format(s):
Vericel® Corporation Email FormatsExamplePercentage
FLast@vcel.comJDoe@vcel.com
91%
FirstLast@vcel.comJohnDoe@vcel.com
6%
First.Last@vcel.comJohn.Doe@vcel.com
2%
FirLast@vcel.comJohDoe@vcel.com
1%

Frequently Asked Questions

What is Vericel® Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Vericel® Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vericel® Corporation's official website and social media links?

Minus sign iconPlus sign icon
Vericel® Corporation's official website is vcel.com and has social profiles on LinkedInCrunchbase.

What is Vericel® Corporation's SIC code NAICS code?

Minus sign iconPlus sign icon
Vericel® Corporation's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Vericel® Corporation have currently?

Minus sign iconPlus sign icon
As of December 2025, Vericel® Corporation has approximately 425 employees across 2 continents, including North AmericaEurope. Key team members include Chief Human Resources Officer: K. M.Chief Medical Officer: J. H.Chief Legal Officer: S. C. F.. Explore Vericel® Corporation's employee directory with LeadIQ.

What industry does Vericel® Corporation belong to?

Minus sign iconPlus sign icon
Vericel® Corporation operates in the Biotechnology Research industry.

What technology does Vericel® Corporation use?

Minus sign iconPlus sign icon
Vericel® Corporation's tech stack includes SASDrupalSQLAdobe Acrobat ProMicrosoft DynamicsGoogle Fonts APIjQuery MobileOffice 365.

What is Vericel® Corporation's email format?

Minus sign iconPlus sign icon
Vericel® Corporation's email format typically follows the pattern of FLast@vcel.com. Find more Vericel® Corporation email formats with LeadIQ.

How much funding has Vericel® Corporation raised to date?

Minus sign iconPlus sign icon
As of December 2025, Vericel® Corporation has raised $75M in funding. The last funding round occurred on Jun 07, 2018 for $75M.

When was Vericel® Corporation founded?

Minus sign iconPlus sign icon
Vericel® Corporation was founded in 1989.

Vericel® Corporation

Biotechnology ResearchMassachusetts, United States201-500 Employees

Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. We currently market two autologous cell therapy products and one specialty biologic product in the United States. 

Personal integrity, teamwork, collaboration, and innovative technology are the foundations of our work.  We seek to practice transparency in our clinical trials and research, and in our relationships with each other, our patients, and the investors who support us.

PRIVACY AND COMMUNITY GUIDELINES 

When you engage with Vericel social media channels and our content providers on social media, you also agree to abide by the following Community Guidelines (found here: https://bit.ly/3pg3UKQ), which apply in addition to the Terms and Conditions or other legal notices specific to each social media channel. 

Please note that third-party social media channels also have access to information you share via social media. For more details, read LinkedIn's Privacy Policy here: https://bit.ly/3GF2r5Y. For additional information about privacy at Vericel, please see our Privacy Policy (bit.ly/43ErZcx) and Terms and Conditions of Use (bit.ly/4568Cdx). 

If you engage with us, you consent and give Vericel permission to communicate with you and to use any information, text and media associated with the interaction or post.

Section iconCompany Overview

Phone number
Website
vcel.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1989
Employees
201-500

Section iconFunding & Financials

  • $75M

    Vericel® Corporation has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Jun 07, 2018 in the amount of $75M.

  • $100M$250M

    Vericel® Corporation's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $75M

    Vericel® Corporation has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Jun 07, 2018 in the amount of $75M.

  • $100M$250M

    Vericel® Corporation's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.